- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Continued and on-going process verification
3 December 2015 • Author: ChemAcademy
The FDA and EU published a lot of guidlines regarding process validation which makes it hard to keep up with all the changes. As a result a lot of questions and uncertanties arise: How can CPV be implemented into daily business? How can companies assure the detection of unplanned deviations in the most economic way? Where are EU’s Guidance, ICH Q8 and CPV blending and how can they be merged and implemented most reasonably? Where does Statistical Process Control (SPC) fit into the CPV plan?
The international conference Continued and On-Going Process Verification in Berlin is created to show best practice cases, answer all the pressing questions and provide networking opportunities.
Bernd Bödecker (GMP Inspectorate of Hannover, Germany) talks about on-going process verification – EU regulatory expectations since the entry of the revised EU GMP Annex 15 into force. Aidan Collins (Eli Lilly Company, Ireland) covers a risk based approach to CPV. The topic María Jesús Alonso (Reig Jofre Group, Spain) is presenting will be APR/PQR in re-validation and technology transfer – implementing CPV into business. A business case for Stage 3: Continued/on-going process verification will be introduced by Ajay Pazhayattil (Apotex Inc., Canada). Ajaz S. Hussain (Insight, Advice & Solutions, LLC (Former FDA Deputy Director), USA) provides an insight into FDA’s trending new validation strategies.
The workshop on the 2nd March covers QbD and Continued Process Verification, including exploring the regulatory landscape, building process knowledge – fact and risk based process design, reaction mechanisms and criticality of organisational structures in addition to the evolution of a CPV programme and opportunities for continuous improvement.
For more information please visit: www.chem-academy.com/cpv
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics